Predictive Oncology Files Definitive Proxy Statement
Ticker: AGPU · Form: DEF 14A · Filed: Nov 27, 2024 · CIK: 1446159
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
PRED filed its proxy statement, standard shareholder info.
AI Summary
Predictive Oncology Inc. filed a Definitive Proxy Statement (DEF 14A) on November 27, 2024, for the fiscal year ending December 30, 2024. The company, formerly known as Skyline Medical Inc., is headquartered in Pittsburgh, PA, and operates in the orthopedic, prosthetic & surgical appliances & supplies industry. This filing is a standard procedural document related to shareholder matters.
Why It Matters
This filing is a routine disclosure required for public companies, providing shareholders with information regarding upcoming meetings and voting matters.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new financial information or strategic changes.
Key Numbers
- 20241230 — Fiscal Year End (Reporting period for the proxy statement.)
- 20241127 — Filing Date (Date the definitive proxy statement was submitted.)
Key Players & Entities
- Predictive Oncology Inc. (company) — Registrant
- Skyline Medical Inc. (company) — Former Company Name
- 20241127 (date) — Filing Date
- 20241230 (date) — Fiscal Year End
- Pittsburgh, PA (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is a document filed with the SEC by a company that is soliciting proxies from its shareholders. It provides detailed information about matters to be voted on at a shareholder meeting, such as director elections, executive compensation, and other corporate proposals.
When is Predictive Oncology Inc.'s fiscal year end?
Predictive Oncology Inc.'s fiscal year ends on December 31st, as indicated by the 'FISCAL YEAR END: 1231' in the filing.
What was Predictive Oncology Inc. formerly known as?
Predictive Oncology Inc. was formerly known as Skyline Medical Inc., with a name change date of August 7, 2013.
Where is Predictive Oncology Inc. located?
Predictive Oncology Inc. is located in Pittsburgh, PA, with its business and mailing address at 91 43rd Street, Suite 110, Pittsburgh, PA 15201.
What is the SIC code for Predictive Oncology Inc.?
The Standard Industrial Classification (SIC) code for Predictive Oncology Inc. is 3842, which pertains to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 4,747 words · 19 min read · ~16 pages · Grade level 10.4 · Accepted 2024-11-27 07:00:22
Key Financial Figures
- $15,000 — . We have agreed to pay Sodali a fee of $15,000, plus out-of-pocket expenses, for these
Filing Documents
- def14a_122724.htm (DEF 14A) — 403KB
- peoav.jpg (GRAPHIC) — 34KB
- peoavsnetloss.jpg (GRAPHIC) — 35KB
- 0001171843-24-006611.txt ( ) — 499KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 15 DIRECTOR COMPENSATION 19 PROPOSAL NO. 2: RATIFICATION OF SELECTION OF INDEPENDENT AUDITORS 24 PROPOSAL No. 3: APPROVAL OF 2024 Equity INCENTIVE PLAN 28 Proposal no. 4: “Say-On-Pay” Vote 32
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 33 FORM 10-K 34 OTHER MATTERS 34 PREDICTIVE ONCOLOGY INC. 91 43 rd Street, Suite 110 Pittsburgh, Pennsylvania Telephone: (412) 432-1500 PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON DECEMBER 30, 2024 QUESTIONS AND ANSWERS Who is soliciting my vote? The Board of Directors (the “Board of Directors” or the “Board”) of Predictive Oncology Inc. (“Predictive” or the “Company”) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders of the Company (the “Annual Meeting”) to be held on December 30, 2024, at 12:00PM (Eastern Time), at the offices of DLA Piper LLP (US) at 1001 Liberty Avenue, Suite 500, Pittsburgh, PA 15222, including any adjournments or postponements of the Annual Meeting. We are first making this Proxy Statement and accompanying materials available to our stockholders on or about November 27, 2024. Am I allowed to attend the Annual Meeting in person? Stockholders may attend the Annual Meeting in person. Any stockholder who desires to attend in person is kindly asked to provide advance written notice to secretary@predictive-oncology.com. If you would like directions to the offices of DLA Piper LLP (US), please call (412) 432-1500. Who can vote at the Annual Meeting? Only stockholders of record at the close of business on November 27, 2024, will be entitled to vote at the Annual Meeting. On the record date, there were 6,666,993 shares of common stock outstanding and entitled to vote. A list of stockholders, as of the record date, will be available for inspection for the ten days prior to the Annual Meeting. If you would like to inspect the stockholder list, contact us at secretary@predictive-oncology.com. Stockholder of Record: Shares Registered in Your Name If, on November 27, 2024, your shares were registered directly in your name with the Company’s tran